68Ga-DOTA-Affibody molecule for in vivo assessment of HER2/neu expression with PET
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
68Ga-DOTA-Affibody molecule for in vivo assessment of HER2/neu expression with PET
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 38, Issue 11, Pages 1967-1976
Publisher
Springer Nature
Online
2011-04-19
DOI
10.1007/s00259-011-1810-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular imaging of HER2-positive breast cancer: a step toward an individualized ‘image and treat’ strategy
- (2010) Jacek Capala et al. CURRENT OPINION IN ONCOLOGY
- Radionuclide Molecular Imaging Using Affibody Molecules
- (2010) Sara Ahlgren et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue
- (2010) Vladimir Tolmachev et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- HER2 as a target for breast cancer therapy
- (2010) Elda Tagliabue et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications
- (2010) J. Löfblom et al. FEBS LETTERS
- Design of an Optimized Scaffold for Affibody Molecules
- (2010) Joachim Feldwisch et al. JOURNAL OF MOLECULAR BIOLOGY
- Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules
- (2010) R. P. Baum et al. JOURNAL OF NUCLEAR MEDICINE
- The HER2 testing conundrum
- (2010) Malorye Allison NATURE BIOTECHNOLOGY
- Structural basis for high-affinity HER2 receptor binding by an engineered protein
- (2010) C. Eigenbrot et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resistance to Trastuzumab in Breast Cancer
- (2009) P. R. Pohlmann et al. CLINICAL CANCER RESEARCH
- A 2-Helix Small Protein Labeled with 68Ga for PET Imaging of HER2 Expression
- (2009) G. Ren et al. JOURNAL OF NUCLEAR MEDICINE
- Changes in HER2 Expression in Breast Cancer Xenografts After Therapy Can Be Quantified Using PET and 18F-Labeled Affibody Molecules
- (2009) G. Kramer-Marek et al. JOURNAL OF NUCLEAR MEDICINE
- On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a 124I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model
- (2009) A. Orlova et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals
- (2008) Melpomeni Fani et al. Contrast Media & Molecular Imaging
- Imaging of HER-2 Overexpression in Tumors for Guiding Therapy
- (2008) V. Tolmachev CURRENT PHARMACEUTICAL DESIGN
- Her2-positive breast cancer: Herceptin and beyond
- (2008) Windy Dean-Colomb et al. EUROPEAN JOURNAL OF CANCER
- Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts
- (2008) Kristin McLarty et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Disparity Between In Vivo EGFR Expression and 89Zr-Labeled Cetuximab Uptake Assessed with PET
- (2008) H. J.W.L. Aerts et al. JOURNAL OF NUCLEAR MEDICINE
- Imaging and cancer: A review
- (2008) Leonard Fass Molecular Oncology
- Evaluation of Maleimide Derivative of DOTA for Site-Specific Labeling of Recombinant Affibody Molecules
- (2007) Sara Ahlgren et al. BIOCONJUGATE CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started